EAM
XFOR icon

Empery Asset Management’s X4 Pharmaceuticals XFOR Stock Holding History

Empery Asset Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4M Sell
6,930,591
-2,013,527
-23% -$8.26M 37.43% 1
2026
Q1 		$36.9M Sell
8,944,118
-6,987
-0.1% -$26.2K 44.5% 1
2025
Q4 		$35.8M Buy
+8,951,105
New +$32.5M 31.57% 1

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Empery Asset Management's XFOR Position: Q2 2026 in Review

Empery Asset Management reduced its X4 Pharmaceuticals (XFOR) stake by 23% in Q2 2026, selling an estimated $8.26M and leaving 6,930,591 shares worth $32.4M. The position accounts for 37.43% of the portfolio, ranked #1.

Empery Asset Management first reported a position in XFOR in Q4 2025 and has held it in 3 quarters since. The position peaked at $36.9M in Q1 2026. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Empery Asset Management held 6,930,591 shares of X4 Pharmaceuticals worth $32.4M as of Q2 2026.
  • Empery Asset Management sold 2,013,527 X4 Pharmaceuticals shares in Q2 2026, an estimated $8.26M.
  • X4 Pharmaceuticals made up 37.43% of Empery Asset Management's portfolio in Q2 2026, its #1 holding.
  • Empery Asset Management first reported a position in X4 Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Empery Asset Management's X4 Pharmaceuticals position peaked at $36.9M in Q1 2026.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Empery Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.